# Dynamics of lung-infiltrating virus-specific T cells associated with age-dependent SARS-CoV-2 pneumonia severity

**Authors:** Rise Kurokawa, Chatherine Silas Mtali, Innocent John Daniel, Thorbjorg Einarsdottir, Omnia Reda, Nobuko Irie, Wajihah Sakhor, Koki Niimura, Mitsuyoshi Takatori, Kenji Sugata, Chanidapa Adele Tye, Yorifumi Satou, Masahiro Ono, Takushi Nomura

PMC · DOI: 10.1371/journal.ppat.1013866 · PLOS Pathogens · 2026-01-14

## TL;DR

This study explores how T-cell responses and lung inflammation in older mice lead to more severe SARS-CoV-2 pneumonia compared to younger mice.

## Contribution

A novel mouse model tracks antigen-reactive T cells in vivo, revealing age-related differences in T-cell dynamics and inflammation linked to SARS-CoV-2 pneumonia severity.

## Key findings

- Adult mice showed transient weight loss and recovery, while aged mice developed severe pneumonia.
- Adult mice exhibited earlier T-cell responses and reduced viral RNA, whereas aged mice had delayed T-cell responses and stronger inflammation.
- Age-related lung inflammation and delayed T-cell induction correlate with more severe SARS-CoV-2 pneumonia.

## Abstract

Coronavirus disease 2019 (COVID-19) pneumonia is prevalent in the elderly infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, the mechanisms underlying its age-dependent pathogenesis remain unclear. In this study, we established a mouse-adapted SARS-CoV-2 strain infected Nr4a3-Tocky mouse model to examine T-cell dynamics associated with disease severity. Nr4a3-Tocky mice allow the analysis of the dynamics and induction of antigen-reactive T cells following antigen recognition in
vivo using fluorescent Timer protein. SARS-CoV-2-infected adult mice exhibited transient body weight loss and recovery, whereas aged mice developed severe pneumonia. BALF viral RNA was comparable between 1–4 days post-inoculation (d.p.i.), but declined in adults at 5 d.p.i. Aged mice displayed stronger inflammation as indicated by scRNA-seq, and higher levels of inflammatory cytokines (TNF-α, CCL2, CXCL10 and IL-6) in BALF correlated with weight loss. Timer analysis revealed induction of antigen-reactive T cells in the adult lungs at 5 and 8 d.p.i., which inversely correlated with disease severity. Additionally, S-specific IFN-γ ⁺ CD8 ⁺ T cells were detected at 5 d.p.i. in adults, whereas detection of antigen-specific T cells was delayed in aged mice. These results suggest that the coexistence of age-related lung inflammation and delayed induction of antigen-specific T cells is linked to more severe pneumonia, while earlier T-cell responses are associated with improved viral control and milder disease. In this study, we utilized a novel mouse model enabling characterization of antigen-reactive T cells in the local tissue, and investigated inflammatory responses in the lung together with lung-infiltrating virus-specific T cells, finding the dynamics of these immunological parameters associated with the age of the mice. Our analysis provides new insights into understanding how age-related T-cell dysfunction is associated with the severity of SARS-CoV-2 pneumonia.

COVID-19 pneumonia is prevalent in the elderly infected with SARS-CoV-2; however, its age-dependent pathogenesis is unclear. We established a SARS-CoV-2-infected Nr4a3-Tocky mouse model, which enables analysis of the dynamics and responses of antigen-reactive T cells, and identified age-dependent disease phenotypes. SARS-CoV-2-infected adult mice exhibited transient body weight loss and recovery, whereas aged mice developed severe pneumonia. SARS-CoV-2-infected adult mice induced T-cell responses in the lungs five days after infection, and showed reduced viral RNA levels in the respiratory tract. In aged mice, induction of T-cell responses was delayed in the context of the stronger inflammatory environment in the lung, and SARS-CoV-2 pneumonia was severe. Across these infected animals, the coexistence of age-related lung inflammation and delayed induction of antigen-specific T cells is linked to more severe pneumonia, while earlier T-cell responses are associated with improved viral control and milder disease. In conclusion, our multilayered analysis of the lung immunological state provides new insights to understanding how age-related T-cell dysfunction is associated with the severity of SARS-CoV-2 pneumonia.

## Linked entities

- **Proteins:** IFNG (interferon gamma), TNF (tumor necrosis factor), CCL2 (C-C motif chemokine ligand 2), CXCL10 (C-X-C motif chemokine ligand 10), IL6 (interleukin 6)
- **Diseases:** COVID-19 (MONDO:0100096)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Siglecf (sialic acid binding Ig-like lectin F) [NCBI Gene 233186] {aka Siglec5, mSiglec-F}, S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}, Ccl3 (C-C motif chemokine ligand 3) [NCBI Gene 20302] {aka G0S19-1, LD78alpha, MIP-1alpha, MIP1-(a), MIP1-alpha, Mip1a}, Cd69 (CD69 antigen) [NCBI Gene 12515] {aka 5830438K24Rik, AIM, VEA}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], AIF1 (allograft inflammatory factor 1) [NCBI Gene 199] {aka AIF-1, IBA1, IRT-1, IRT1}, Ly6c1 (lymphocyte antigen 6 family member C1) [NCBI Gene 17067] {aka Ly-6C, Ly-6C1, Ly6c}, Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, Vtn (vitronectin) [NCBI Gene 22370] {aka Vn}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, Cxcl10 (C-X-C motif chemokine ligand 10) [NCBI Gene 15945] {aka C7, CRG-2, INP10, IP-10, IP10, Ifi10}, Gem (GTP binding protein overexpressed in skeletal muscle) [NCBI Gene 14579], Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, Tmprss2 (transmembrane protease, serine 2) [NCBI Gene 50528] {aka D16Ertd61e}, Isg15 (ISG15 ubiquitin-like modifier) [NCBI Gene 100038882] {aka G1p2, IGI15, IP17, Irfp, UCRP}, Tnfrsf4 (tumor necrosis factor receptor superfamily, member 4) [NCBI Gene 22163] {aka ACT35, CD134, Ly-70, Ox40, TXGP1L, Txgp1}, Il2ra (interleukin 2 receptor, alpha chain) [NCBI Gene 16184] {aka CD25, Il2r, Ly-43}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Ifnb1 (interferon beta 1, fibroblast) [NCBI Gene 15977] {aka IFN-beta, IFNB, If1da1, Ifb}, N (nucleocapsid phosphoprotein) [NCBI Gene 43740575], Tcra (T cell receptor alpha chain) [NCBI Gene 21473] {aka Tcralpha}, Fcgr2b (Fc receptor, IgG, low affinity IIb) [NCBI Gene 14130] {aka CD32, F630109E10Rik, Fc[g]RII, FcgRII, Fcgr2, Fcgr2a}, Trav6-3 (T cell receptor alpha variable 6-3) [NCBI Gene 328483] {aka Gm13948, Gm193, Gm4, TCR}, Nr4a3 (nuclear receptor subfamily 4, group A, member 3) [NCBI Gene 18124] {aka CHN, CSMF, MINOR, NOR-1, Nor1, TEC}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Foxp3 (forkhead box P3) [NCBI Gene 20371] {aka JM2, scurfin, sf}, Tcrb (T cell receptor beta chain) [NCBI Gene 21577] {aka TCRbeta, Tib}, Fcgr3 (Fc receptor, IgG, low affinity III) [NCBI Gene 14131] {aka CD16}
- **Diseases:** infected (MESH:D007239), T-cell dysfunction (MESH:C536780), obesity (MESH:D009765), infectious disease (MESH:D003141), weight loss (MESH:D015431), edema (MESH:D004487), COVID-19 (MESH:D000086382), diabetes (MESH:D003920), inflammatory cytokines (MESH:D000080424), viral infections (MESH:D014777), lung infection (MESH:D012141), lung inflammation (MESH:D011014), inflammation (MESH:D007249), Lung (MESH:D008171), respiratory distress (MESH:D012128)
- **Chemicals:** Brefeldin A (MESH:D020126), glucose (MESH:D005947), S (MESH:D013455), Alexa Fluor 647 (MESH:C569686), midazolam (MESH:D008874), BUV805 (-), eosin (MESH:D004801), H&amp;E (MESH:D006371), penicillin (MESH:D010406), phosphate (MESH:D010710), PFA (MESH:C003043), Triton X-100 (MESH:D017830), BD (MESH:C028491), streptomycin (MESH:D013307), geneticin (MESH:C010680), paraffin (MESH:D010232), PBS (MESH:D007854), Cy5.5 (MESH:C098793), hematoxylin (MESH:D006416)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Cricetinae (hamsters, subfamily) [taxon 10026], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S17007L
- **Cell lines:** PN-1000265 — Homo sapiens (Human), Primitive neuroectodermal tumor, Cancer cell line (CVCL_VK47), VeroE6 — Chlorocebus sabaeus (Green monkey), Spontaneously immortalized cell line (CVCL_0574), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12829949/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12829949/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC12829949/full.md

---
Source: https://tomesphere.com/paper/PMC12829949